Cargando…
Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar
Tumor necrosis factor-α inhibitors are monoclonal antibodies that are commonly used in the treatment of inflammatory bowel disease. A rare side effect of these biological agents is chronic inflammatory demyelinating polyneuropathy, which is a debilitating disease characterized by weakness, sensory d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946395/ https://www.ncbi.nlm.nih.gov/pubmed/36846359 http://dx.doi.org/10.14309/crj.0000000000000993 |